Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1978 2
1979 2
1980 3
1981 3
1982 4
1983 4
1984 11
1985 5
1986 6
1987 5
1988 6
1989 3
1991 3
1992 2
1993 3
1994 3
1995 7
1996 5
1997 5
1998 9
1999 9
2000 4
2001 2
2002 3
2003 2
2004 5
2005 4
2006 6
2007 1
2008 3
2009 3
2010 3
2011 1
2012 2
2013 3
2014 2
2015 1
2016 6
2017 2
2018 3
2019 6
2020 7
2021 3
2022 10
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Oxaprozin.
[No authors listed] [No authors listed] 2020 Mar 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Mar 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643656 Free Books & Documents. Review.
Oxaprozin is a long acting nonsteroidal antiinflammatory drug (NSAID) available by prescription only which is used for therapy of chronic arthritis. Oxaprozin has been linked to rare instances of idiosyncratic drug induced liver disease....
Oxaprozin is a long acting nonsteroidal antiinflammatory drug (NSAID) available by prescription only which is used for therapy of chr …
Oxaprozin.
[No authors listed] [No authors listed] 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000217 Free Books & Documents. Review.
Because there is no published experience with oxaprozin during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant....
Because there is no published experience with oxaprozin during breastfeeding, other agents may be preferred, especially while nursing …
Clinical pharmacokinetics of oxaprozin.
Davies NM. Davies NM. Clin Pharmacokinet. 1998 Dec;35(6):425-36. doi: 10.2165/00003088-199835060-00002. Clin Pharmacokinet. 1998. PMID: 9884815 Review.
Oxaprozin binds extensively, in a concentration-dependent manner, to plasma albumin. ...Hepatic disease and rheumatoid arthritis do not significantly alter the disposition of oxaprozin. Patients with renal impairment demonstrate an increase in unbound plasma concent …
Oxaprozin binds extensively, in a concentration-dependent manner, to plasma albumin. ...Hepatic disease and rheumatoid arthritis do n …
Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Todd PA, Brogden RN. Todd PA, et al. Drugs. 1986 Oct;32(4):291-312. doi: 10.2165/00003495-198632040-00001. Drugs. 1986. PMID: 3536423 Review.
Oxaprozin is a newer non-steroidal anti-inflammatory drug advocated for use in painful rheumatic and inflammatory conditions. ...More controlled clinical trials in adequate numbers of patients are necessary to evaluate its potential in other rheumatic and inflammatory cond …
Oxaprozin is a newer non-steroidal anti-inflammatory drug advocated for use in painful rheumatic and inflammatory conditions. ...More …
Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug.
Miller LG. Miller LG. Clin Pharm. 1992 Jul;11(7):591-603. Clin Pharm. 1992. PMID: 1617910 Review.
Oxaprozin is primarily eliminated by urinary excretion of the unchanged drug. ...Oxaprozin, like other NSAIDs, can cause gastrointestinal adverse effects. ...
Oxaprozin is primarily eliminated by urinary excretion of the unchanged drug. ...Oxaprozin, like other NSAIDs, can cause gastr …
Oxaprozin: A new hope in the modulation of matrix metalloproteinase 9 activity.
Ianni A, Celenza G, Franceschini N. Ianni A, et al. Chem Biol Drug Des. 2019 May;93(5):811-817. doi: 10.1111/cbdd.13468. Epub 2019 Jan 11. Chem Biol Drug Des. 2019. PMID: 30582279
The interaction between oxaprozin and MMP-9 was firstly investigated in silico by molecular docking and analysis with LIGPLOT software. Subsequently, the potential inhibitory activity of oxaprozin against MMP-9 and the possible mechanism of the ligand-enzyme interac …
The interaction between oxaprozin and MMP-9 was firstly investigated in silico by molecular docking and analysis with LIGPLOT softwar …
Oxaprozin-induced pseudoporphyria.
Ingrish G, Rietschel RL. Ingrish G, et al. Arch Dermatol. 1996 Dec;132(12):1519-20. Arch Dermatol. 1996. PMID: 8961891 No abstract available.
Oxaprozin: kinetic and dynamic profile in the treatment of pain.
Kean WF. Kean WF. Curr Med Res Opin. 2004 Aug;20(8):1275-7. doi: 10.1185/030079904125004420. Curr Med Res Opin. 2004. PMID: 15324530
Both oxaprozin and diclofenac compared well in the primary study endpoint of reduction in shoulder pain. Oxaprozin and diclofenac were well tolerated and oxaprozin showed better improvement in shoulder function and in the mental health item of the SF-36 quali …
Both oxaprozin and diclofenac compared well in the primary study endpoint of reduction in shoulder pain. Oxaprozin and diclofe …
Oxaprozin prodrug as safer nonsteroidal anti-inflammatory drug: Synthesis and pharmacological evaluation.
Peesa JP, Atmakuri LR, Yalavarthi PR, Mandava Venkata BR, Rasheed A, Pachava V. Peesa JP, et al. Arch Pharm (Weinheim). 2018 Feb;351(2). doi: 10.1002/ardp.201700256. Epub 2017 Dec 28. Arch Pharm (Weinheim). 2018. PMID: 29283449
Dextran of average molecular weight (60,000-90,000 Da) was exploited as a carrier in the process of oxaprozin prodrug production by esterification. The structural profiles of the synthesized oxaprozin prodrug were characterized by FT-IR and NMR spectroscopy. ...Thus …
Dextran of average molecular weight (60,000-90,000 Da) was exploited as a carrier in the process of oxaprozin prodrug production by e …
Oxaprozin-induced fulminant hepatitis.
Purdum PP 3rd, Shelden SL, Boyd JW, Shiffman ML. Purdum PP 3rd, et al. Ann Pharmacother. 1994 Oct;28(10):1159-61. doi: 10.1177/106002809402801004. Ann Pharmacother. 1994. PMID: 7841569
OBJECTIVE: To report oxaprozin-induced fulminant hepatic failure. CASE SUMMARY: A 56-year-old woman was admitted with fulminant hepatic failure. ...DISCUSSION: Although the literature describes elevation in hepatic transaminase concentrations associated with oxaprozin …
OBJECTIVE: To report oxaprozin-induced fulminant hepatic failure. CASE SUMMARY: A 56-year-old woman was admitted with fulminant hepat …
183 results